Estradiol/testosterone imbalance: Impact on coronary heart disease risk factors in postmenopausal women

Cardiology (Switzerland)

Volumn 121, Issue 4, 2012, Pages 249-254

  Dai, Wen ^a   Li, Yan ^a   Zheng, Hongyun ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Coronary heart disease; Estradiol testosterone ratio; Postmenopausal women

Indexed keywords

AROMATASE; C REACTIVE PROTEIN; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; LIPOPROTEIN;

AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY RISK; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE LINEAR REGRESSION ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; BLOOD; CORONARY ARTERY DISEASE; MIDDLE AGED;

AGED; AROMATASE; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; ESTRADIOL; FEMALE; HUMANS; LIPOPROTEINS; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84860845869     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000337274     Document Type: Article

References (33)

1. Rappelli A: Hypertension and obesity after the menopause. J Hypertens Suppl 2002;20:S26-S28.
2. Lambrinoudaki I, Christodoulakos G, Rizos D, et al: Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol 2006;154:907-916. (Pubitemid 43997731)
3. Chen Y, Zeleniuch-Jacquotte A, Arslan AA, et al: Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis 2011;216:414-419.
4. Karim R, Hodis HN, Stanczyk FZ, et al: Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2008;93:131-138.
5. Manolio TA, Furberg CD, Shemanski L, et al: Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group. Circulation 1993;88:2163-2171. (Pubitemid 23326096)
6. Golden SH, Maguire A, Ding J, et al: Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 2002;155:437-445. (Pubitemid 34174155)
7. Kumagai S, Kai Y, Sasaki H: Relationship between insulin resistance, sex hormones and sex hormone-binding globulin in the serum lipid and lipoprotein profiles of Japanese postmenopausal women. J Atheroscler Thromb 2001;8:14-20.
8. Rexrode KM, Manson JE, Lee IM, et al: Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003;108:1688-1693. (Pubitemid 37243655)
9. Bernini GP, Sgro M, Moretti A, et al: Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 1999;84:2008-2012. (Pubitemid 30647026)
10. Reinecke H, Bogdanski J, Woltering A, et al: Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol 2002;90:364-368.
11. Mudali S, Dobs AS, Ding J, et al: Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab 2005;90:1202-1209. (Pubitemid 40279255)
12. Phillips GB, Pinkernell BH, Jing TY: Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 1997;17:695-701. (Pubitemid 27169130)
13. Brown TM, Bittner V: Management of stable patients with coronary heart disease: clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. J Clin Lipidol 2007;1:564-574. (Pubitemid 350218046)
14. Sowers MR, Randolph J Jr, Jannausch M, et al: Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the 'timing hypothesis'. Arch Intern Med 2008;168:2146-2153.
15. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
16. Tan MH, Johns D, Glazer NB: Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem 2004;50:1184-1188. (Pubitemid 38824226)
17. Slinker BK, Glantz SA: Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable. Circulation 2008;117:1732-1737. (Pubitemid 351482596)
18. Masood DE, Roach EC, Beauregard KG, et al: Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr Drug Metab 2010;11:693-714.
19. Maturana MA, Moreira RM, Spritzer PM: Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women. Maturitas 2011;70:395-399.
20. Krause DN, Duckles SP, Gonzales RJ: Local oestrogenic/androgenic balance in the cerebral vasculature. Acta Physiol (Oxf) 2011;203:181-186.
21. Dobiasova M: AIP - atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice (in Czech). Vnitr Lek 2006;52:64-71.
22. Beitelshees AL, Johnson JA, Hames ML, et al: Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner. PLoS One 2010;5:e15180.
23. Rosner W: Plasma steroid-binding proteins. Endocrinol Metab Clin North Am 1991;20:697-720.
24. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al: Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111:1242-1249. (Pubitemid 40389087)
25. de Moor P, Joossens JV: An inverse relation between body weight and the activity of the steroid binding globulin in human plasma. Steroidologia 1970;1:129-136.
26. Cauley JA, Gutai JP, Kuller LH, et al: The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women. Am J Epidemiol 1990;132:884-894. (Pubitemid 20363667)
27. Goodman-Gruen D, Barrett-Connor E: Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study. Diabetes Care 1997;20:645-649. (Pubitemid 27143431)
28. Brand JS, van der Schouw YT: Testosterone, SHBG and cardiovascular health in post-menopausal women. Int J Impot Res 2010;22:91-104.
29. Bairey Merz CN, Johnson BD, Sharaf BL, et al: Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003;41:413-419. (Pubitemid 36164495)
30. Ossewaarde ME, Bots ML, van der Schouw YT, et al: Plasma and urinary sex hormones are differently related to lipids in healthy postmenopausal women. Maturitas 2003;44:181-187. (Pubitemid 36315814)
31. Villablanca AC, Jayachandran M, Banka C: Atherosclerosis and sex hormones: current concepts. Clin Sci (Lond) 2010;119:493-513.
32. Vitale C, Mendelsohn ME, Rosano GM: Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009;6:532-542.
33. Bruck B, Brehme U, Gugel N, et al: Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1997;17:2192-2199. (Pubitemid 28057121)